La vacuna contra el virus del papiloma humano: Estado de la cuestión, principio de proporcionalidad y consentimiento informado

Translated title of the contribution: The vaccine against human papilloma virus: State of the question, proportionality principle and informed consent

Research output: Contribution to journalArticlepeer-review

Abstract

Within the current discussions on immunization practices, Human Papillomavirus (HPV) made various challenges from bioethics: firstly, there are controversies regarding the efficacy and safety profile of marketed vaccines, and with respect to their cost-effectiveness. Around the discussion is evident in empirical studies that the informed consent process does not provide the necessary elements for the patients and their legal representatives can participate meaningfully in the process of making decisions about vaccination. This article presents an overview of the status of the issue, with an analysis from bioethics from the principle of proportionality and the deliberative syncretic method and suggests some input to optimize the process of informed consent for the HPV vaccine.

Translated title of the contributionThe vaccine against human papilloma virus: State of the question, proportionality principle and informed consent
Original languageSpanish
Pages (from-to)251-261
Number of pages11
JournalActa Bioethica
Volume22
Issue number2
DOIs
StatePublished - Nov 2016
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Health(social science)
  • Health Policy

Fingerprint Dive into the research topics of 'The vaccine against human papilloma virus: State of the question, proportionality principle and informed consent'. Together they form a unique fingerprint.

Cite this